Provided by Tiger Trade Technology Pte. Ltd.

CH BIOTECH SER

0.535
0.000
Volume:350.00K
Turnover:190.90K
Market Cap:522.02M
PE:-7.59
High:0.550
Open:0.550
Low:0.545
Close:0.535
52wk High:1.050
52wk Low:0.300
Shares:975.73M
HK Float Shares:975.73M
Volume Ratio:2.42
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.070
ROE:-14.96%
ROA:-8.54%
PB:2.41
PE(LYR):-7.59
PS:6.08

Loading ...

China Biotech Services: Share Capital Steady in September 2026, Convertible Bonds Hold 455 Million Potential New Shares

Bulletin Express
·
Oct 06

China Biotech Services Publishes 2026 Interim Report Online; Shareholders Invited to Opt for E-Notifications

Bulletin Express
·
Sep 30

China Biotech Services Expands Global Reach: New Cross-Border Referral Network Brings BNCT Cancer Therapy to International Patients

Stock News
·
Sep 03

China Biotech Services Signs Cross-Border BNCT Clinical Services Cooperation Pact with OncoCare

Reuters
·
Sep 03

CH BIOTECH SER (08037) Signs Collaborative Accord Linking Hainan Boron Neutron Facility with Hong Kong Cancer Centre

Stock News
·
Sep 03

China Biotech Services Signs One-Year Framework with Tamarind Health’s OncoCare to Channel Overseas Patients to Hainan BNCT Hospital

Bulletin Express
·
Sep 03

China Biotech Services - Pengbo (Hainan) Bnct Hospital Enters Cooperation Agreement with Oncocare on Sept 2, 2026

THOMSON REUTERS
·
Sep 03

China Biotech Services Holdings Ltd - Cooperation Agreement in Relation to Cross-Border Bnct Clinical Services

THOMSON REUTERS
·
Sep 03

China Biotech Services Reports Stable Share Base; 455 Million Shares Potentially Dilutive from Outstanding USD 41 Million Convertible Bonds

Bulletin Express
·
Sep 01

China Biotech Services Holdings Turns Profitable in First Half with HK$18.23 Million Net Gain

Stock News
·
Aug 29

China Biotech Services Swings to FY26 H1 Profit of HK$ 15.06 Million; Revenue Rises 49.7% to HK$ 37.23 Million

Reuters
·
Aug 28

China Biotech Services - Revenue from Cont Ops for Six Months Ended June 30, 2026 Hk$37.23 Mln

THOMSON REUTERS
·
Aug 28

China Biotech Services Holdings Ltd - Hy Profit Attributable Hk$18.2 Mln

THOMSON REUTERS
·
Aug 28

China Biotech Services Holdings Ltd - Board Has Resolved not to Declare Any Dividend for Period Ended 30 June 2026

THOMSON REUTERS
·
Aug 28

China Biotech Services Completes Disposal of PHC and PMS, Accelerates Pivot to BNCT Platform

Bulletin Express
·
Aug 13

China Biotech Services Completes Sale of PHC Medical Diagnostic Centre, Premier Medicare Services Shares

Reuters
·
Aug 13

China Biotech Services Expects H1 Net Profit of at Least HK$15 Million, Swings from Loss

Reuters
·
Aug 12

China Biotech Services forecasts ≥ HK$15.00 million interim profit, reversing prior HK$37.00 million loss on convertible-bond revaluation gains

Bulletin Express
·
Aug 12

China Biotech Services Schedules 28 Aug 2026 Board Meeting to Review 1H26 Results and Potential Dividend

Bulletin Express
·
Aug 12

China Biotech Services - Expects Net Profit of not Less than Hk$15.0 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 12